Medtronic Terminate AF Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 160 participants.

Also called NCT03546374

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03546374
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT03546374. Allocation not applicable; no masking; primary purpose treatment. Start 2018-11-15 (actual); primary completion 2024-10-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Medtronic Terminate AF Study
Condition
Persistent Atrial Fibrillation
Condition
Longstanding Persistent Atrial Fibrillation
Intervention (Procedure)
Surgical Ablation
Intervention (Device)
Cardioblate and Cryoflex hand held devices
Lead sponsor
Medtronic Cardiac Surgery (class: industry)

Record details

Record id
cardio:ct-nct03546374
Content hash
06dfc61014efec45e95fb5ea09a54e6fa87554ffc384bce9a6f39280dbb05052